Ajanta Pharma informs about updates

26 Jun 2023 Evaluate

Ajanta Pharma has informed that its formulation facility at Dahej was inspected by US FDA from 19th June 2023 to 23rd June 2023. At the end of inspection, no Form 483 was issued to them.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2380.30 0.00 (0.00%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.